InvestorsHub Logo
Followers 840
Posts 120476
Boards Moderated 18
Alias Born 09/05/2002

Re: tony111 post# 13411

Sunday, 04/19/2015 8:16:08 PM

Sunday, April 19, 2015 8:16:08 PM

Post# of 20689

The royalty is certainly enough to further develop MNTA's novel drugs that seem extremely promising.

Just to be clear: MNTA does not earn a royalty on Copaxone sales, but rather a 50% share of the (pre-tax) profits.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”